Novavax incurred a third-quarter 2024 loss of 76 cents per share, narrower than the Zacks Consensus Estimate of a loss of 87 cents. In the year-ago quarter, the company reported a loss of $1.26 per ...
Trump's RFK Jr. appointment sends stock market into meltdown - as his full plan to 'make America healthy again' is revealed; ...
President-elect Donald Trump said he is tapping Robert F. Kennedy Jr., to run the Department of Health and Human Services, a ...
Trump announced his decision in a tweet following media reports that Kennedy would be his choice to lead the federal health ...
Donald Trump nominated Robert F. Kennedy Jr., a vaccine skeptic and harsh critic of federal health agencies, to be his ...
Trump may appoint Robert F. Kennedy Jr. as HHS Secretary, stirring mixed reactions. Kennedy's views on vaccines could reshape ...
Vaccine maker shares closed lower Thursday amid reports that Donald Trump was set to nominate vaccine critic Robert F.
In June, GSK released results from an interim analysis of the DREAMM-8 phase 3 head-to-head trial of Blenrep in combination with pomalidomide plus dexamethasone (PomDex), versus a standard of care, ...
In other developments, Alveo Technologies announced an agreement with CDC to develop a rapid multiplex test for point-of-need ...
Inovio Pharmaceuticals Inc.-3.88% $128.52M ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback